If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
ROPIBAM 0.2% Ropivacaine hydrochloride 400mg/200mL solution for injection bag AUST R: 186571Active ingredients:
ropivacaine hydrochloride
Dosage form:
Injection, solution
Sponsor:
Boucher & Muir Pty Ltd
Phone:
1800 627 680
|
From
11 Nov 2024
to
31 Dec 2025
|
Shortage status:
Current
Availability:
Unavailable
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative generic products are available.
|
NAROPIN 0.2% ropivacaine hydrochloride 200mg/100mL injection bag AUST R: 52396Active ingredients:
ropivacaine hydrochloride
Dosage form:
Injection, solution
Sponsor:
Aspen Pharmacare Australia Pty Ltd
Phone:
1300659646
|
Deletion from market:
30 Jun 2025
|
Shortage status:
To be discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative generic products are available.
|
NAROPIN 0.2% ropivacaine hydrochloride 400mg/200mL injection bag AUST R: 52395Active ingredients:
ropivacaine hydrochloride
Dosage form:
Injection, solution
Sponsor:
Aspen Pharmacare Australia Pty Ltd
Phone:
1300659646
|
Deletion from market:
06 Feb 2025
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative generic products are available.
|
NAROPIN 0.2% WITH FENTANYL 200 microgram/100mL ropivacaine hydrochloride 2mg/mL and fentanyl 2 microgram/mL (as citrate) 100mL injection bag AUST R: 72874Active ingredients:
fentanyl citrate
ropivacaine hydrochloride
Dosage form:
Injection, solution
Sponsor:
Aspen Pharmacare Australia Pty Ltd
Phone:
1300659646
|
Deletion from market:
20 Mar 2025
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative presentations of the active ingredients are available.
|
NAROPIN 0.2% WITH FENTANYL 400 microgram/100mL ropivacaine hydrochloride 2 mg/mL and fentanyl 4 microgram/mL (as citrate) 100ml injection bag AUST R: 72876Active ingredients:
fentanyl citrate
ropivacaine hydrochloride
Dosage form:
Injection, solution
Sponsor:
Aspen Pharmacare Australia Pty Ltd
Phone:
1300659646
|
Deletion from market:
06 Feb 2025
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative presentations of the active ingredients are available.
|
NAROPIN 0.2% WITH FENTANYL 400 microgram/200mL ropivacaine hydrochloride 2 mg/mL and fentanyl 2 microgram/mL (as citrate) 200mL injection bag AUST R: 72873Active ingredients:
fentanyl citrate
ropivacaine hydrochloride
Dosage form:
Injection, solution
Sponsor:
Aspen Pharmacare Australia Pty Ltd
Phone:
1300
|
Deletion from market:
01 May 2025
|
Shortage status:
Discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative presentations of the active ingredients are available.
|
NAROPIN 0.2% WITH FENTANYL 800 microgram/200mL ropivacaine hydrochloride 2 mg/mL and fentanyl 4 microgram/mL (as citrate) 200mL injection bag AUST R: 72875Active ingredients:
fentanyl citrate
ropivacaine hydrochloride
Dosage form:
Injection, solution
Sponsor:
Aspen Pharmacare Australia Pty Ltd
Phone:
1300659646
|
Deletion from market:
06 Feb 2025
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative presentations of the active ingredients are available.
|
Ropivacaine-AFT 0.2% ropivacaine hydrochloride 200 mg/100 mL solution for infusion bag AUST R: 310404Active ingredients:
ropivacaine hydrochloride
Dosage form:
Injection, intravenous infusion
Sponsor:
AFT Pharmaceuticals Pty Ltd
Phone:
02 94200420
|
Deletion from market:
13 Sep 2023
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative generic products are available.
|